Newsroom | 322389 results
Sorted by: Latest
-
Resumen: Graanul anuncia un acuerdo con el 50 % de los tenedores de bonos para prorrogar hasta 2029 el vencimiento de los bonos vigentes, por un importe total de 630 millones de euros
LUXEMBURGO--(BUSINESS WIRE)--Cullinan Holdco SCSp (el "emisor" y conjuntamente con sus filiales, "Graanul" o el "grupo") tiene el orgullo de anunciar que ha suscrito un acuerdo de apoyo a la transacción (el "acuerdo de apoyo a la transacción") con los tenedores de los bonos (los "titulares participantes") que representan conjuntamente el 50 % del capital inicial total de sus (i) bonos senior garantizados vinculados a la sostenibilidad al 4,625 % con vencimiento en 2026 (los "bonos a tasa fija v...
-
Riassunto: Graanul annuncia di avere siglato un accordo con il 50% dei titolari delle obbligazioni per estendere la scadenza di attuali obbligazioni per un valore nominale complessivo di 630 milioni di euro fino al 2029
LUSSEMBURGO--(BUSINESS WIRE)--Cullinan Holdco SCSp (l’“Emittente” e, insieme alle sue affiliate, “Graanul” o il “ Gruppo”) annuncia di avere stipulato un accordo di supporto alla transazione (l’“Accordo di supporto alla transazione”) con vari obbligazionisti (i “Partecipanti all’accordo”) che rappresentano collettivamente il 50% del valore nominale complessivo delle sue (i) obbligazioni senior garantite a tasso fisso indicizzate alla sostenibilità con cedola del 4,625% in scadenza nel 2026 (le...
-
Společnost Multiply Group dokončila akvizici společnosti Tendam, zdvojnásobila provozní EBITDA a rozšířila svou globální působnost
ABÚ ZABÍ, Spojené arabské emiráty & MADRID & LONDÝN & LUCEMBURK & PAŘÍŽ--(BUSINESS WIRE)--Multiply Group (ADX: MULTIPLY), investiční holdingová společnost se sídlem v Abú Dhabí, která investuje a provozuje podniky po celém světě, dnes dokončila svou první významnou investici v Evropě akvizicí většinového podílu ve společnosti Tendam, druhé největší oděvní skupině ve Španělsku podle tržního podílu1. Tato transakce zdvojnásobuje provozní EBITDA společnosti Multiply po konsolidaci a rozšiřuje její...
-
Securities Fraud Investigation Into Molina Healthcare, Inc. (MOH) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON MOLINA HEALTHCARE, INC. (MOH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On July 7, 2025, Molina provided preliminary financial results...
-
CORRECTING and REPLACING Zip Marks Fifth Anniversary with New Offices in San Francisco and New York
SAN FRANCISCO--(BUSINESS WIRE)--Zip Marks Fifth Anniversary with New Offices in San Francisco and New York Amid Explosive Growth; Surpasses Billions in Processed Requests...
-
CARGO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CARGO Therapeutics, Inc. - CRGX
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of CARGO Therapeutics, Inc. (NasdaqGS: CRGX) to Concentra Biosciences, LLC. Under the terms of the proposed transaction, Concentra will acquire CARGO for $4.379 in cash per share, plus one non-transferable contingent value right, representing the right to receive: (i) 100% of the closing net cash of CA...
-
TC BANCSHARES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TC Bancshares, Inc. - TCBC
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of TC Bancshares, Inc. (OTC: TCBC) to Colony Bankcorp, Inc. (NYSE: CBAN). Under the terms of the proposed transaction, shareholders of TC will have the right to elect to receive either $21.25 in cash or 1.25 shares of Colony’s common stock in exchange for each share of TC Bancshares common stock,...
-
Accord annonce une mise à jour de sa facilité bancaire
TORONTO--(BUSINESS WIRE)--Accord Financial Corp. (« Accord » ou la « Société ») (TSX – ACD) annonce aujourd’hui être parvenue à un accord avec son syndicat prêteur visant une prolongation à court terme de sa principale facilité de crédit du 26 juillet 2025 au 8 août 2025. La Société et ses prêteurs sont en discussion relativement à une modification de la facilité de crédit qui devrait prolonger la date d'échéance jusqu'en décembre 2025, et la prolongation donnera plus de temps pour que cette mo...
-
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Maravai LifeSciences Holdings, Inc. (NasdaqGS: MRVI). On February 25, 2025, the Company disclosed that it would delay filing its annual report on Form 10-K for the fiscal year ended December 31, 2024 and fiscal 2024 earnings release due to an error in revenue recognition...
-
IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into iRhythm Technologies, Inc. (NasdaqGS: IRTC). On May 30, 2023, the Company disclosed the receipt of a Warning Letter from the FDA regarding “non-conformities to regulations for medical devices, including medical device reporting requirements, relating to the Company’s Zio AT...
